Sana’a: An expanded meeting was held on Wednesday in al-Thawra district of the capital Sana’a to discuss the preparations for a field survey of neighborhoods and districts as part of an economic, developmental, and service-oriented empowerment plan. T…
Month: February 2026
Opening of Workshop and Marketing Center for Productive Families’ Clothing and Cotton Goods in Ibb
Sana’a: Ibb Governor Abdulwahid Salah inaugurated a workshop and marketing center for productive families specializing in clothing, cotton products, and leather goods in the governorate center. The project was funded by the Zakat Office in the governo…
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed as Helus Pharma advances its […]